SCHEMBL345363

SCHEMBL345363

CC(C)c1cc(C(C)C)c(S(=O)O)c(C(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.50
FABP3 P05413 2/20 0.50
FABP5 Q01469 1/20 0.48
GABRA1 P14867 4/20 0.47
GABRB2 P47870 2/20 0.47
SOAT2 O75908 1/20 0.33
MYC P01106 1/20 0.33
SOAT1 P35610 1/20 0.33
MAP2K3 P46734 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
GAA P10253 1/20 0.33
ALDH1A1 P00352 3/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
GABRB1 P18505 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1021280 0.98 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
Calcium SCHEMBL29853758 0.98 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL1033044 0.98 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL346544 0.98 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL1022543 0.98 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
Sulfurous Acid SCHEMBL30356309 0.92 FABP4 (0.44) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL15741262 0.78 FABP4 (0.50) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL13970208 0.78 GSR (0.35) CA1CA2
SCHEMBL1021278 0.77 FABP4 (0.44) FABP4FABP3FABP5GABRA1GABRB2
Lithium Ion SCHEMBL1033043 0.77 FABP4 (0.44) FABP4FABP3FABP5GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2110392-B1 DIVIDED REDOX-CURING-TYPE COMPOSITION KURARAY NORITAKE DENTAL INC (JP) 2020-05-06 EP claimed
EP-2226060-B1 CEMENT FOR DENTAL APPLICATIONS KURARAY NORITAKE DENTAL INC (JP) 2020-03-04 EP claimed
EP-2409997-B1 REDOX-CURING TYPE COMPOSITION KURARAY NORITAKE DENTAL INC (JP) 2016-11-16 EP claimed
US-8329845-B2 Divided redox-curing type composition KURARAY NORITAKE DENTAL INC. (JP) 2012-12-11 US claimed
US-6984673-B2 Dental cement composition KURARAY CO., LTD. (JP) 2006-01-10 US claimed
US-20260144714-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2026-05-28 US disclosed
US-12622847-B2 Organosilicon compound and dental composition containing same KURARAY NORITAKE DENTAL INC. (JP) 2026-05-12 US disclosed
EP-4725470-A1 CURABLE DENTAL COMPOSITION Kuraray Noritake Dental Inc. (JP) 2026-04-15 EP disclosed
EP-3733152-B1 POWDER-LIQUID TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION SHOFU INC (JP) 2026-03-11 EP disclosed
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT SHOFU INC. (JP) 2026-03-05 US disclosed
EP-4659729-A1 DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION Shofu Inc. (JP) 2025-12-10 EP disclosed
US-12478562-B2 Dental restoration material composition KURARAY NORITAKE DENTAL INC. (JP) 2025-11-25 US disclosed
US-20020198284-A1 Adhesive composition KURARAY CO. LTD, (JP) 2002-12-26 US disclosed
US-20020061938-A1 Bonding composition KURARAY CO., LTD. (JP) 2002-05-23 US disclosed
US-6387979-B1 FOR TOOTH TISSUE KURARAY CO., LTD. (JP) 2002-05-14 US disclosed
CN-1277834-A Cementation composite and prepn. method therefor KURARAY CO (JP) 2000-12-27 CN disclosed
EP-1057468-A1 Adhesive composition and method for producing it KURARAY CO., LTD. (JP) 2000-12-06 EP disclosed
CN-1273809-A Binding compsns. KURARAY CO (JP) 2000-11-22 CN disclosed
EP-1051961-A1 Bonding compositions for dental use KURARAY CO., LTD. (JP) 2000-11-15 EP disclosed
CN-1253767-A Adhesive compound for tooth KURARAY CO (JP) 2000-05-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT BOLA2; BOLA2B, LBR, COL2A1 FABP4 509/4885FABP3 2618/4885FABP5 1684/4885
US-20260144714-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL CAD, KIT, ILK FABP4 4457/4885FABP3 4643/4885FABP5 4348/4885
US-12478562-B2 Dental restoration material composition CAD, MAT2B, RER1 FABP4 3087/4885FABP3 4243/4885FABP5 3635/4885
US-12622847-B2 Organosilicon compound and dental composition containing same MSL1, ITGA1, ITGAL FABP4 4707/4885FABP3 4366/4885FABP5 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.